Philadelphia, PA, United States of America

Sanjeevani Arora

USPTO Granted Patents = 2 

Average Co-Inventor Count = 4.4

ph-index = 1


Company Filing History:


Years Active: 2020-2023

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Sanjeevani Arora: Innovator in Cancer Research

Introduction

Sanjeevani Arora is a prominent inventor based in Philadelphia, PA (US), known for his significant contributions to cancer research. He has been instrumental in developing innovative methods for diagnosing and treating patients with solid tumors. With a total of 2 patents, his work is paving the way for advancements in oncology.

Latest Patents

Sanjeevani Arora's latest patents include groundbreaking methods for the diagnosis and treatment of patients with solid tumors. One patent focuses on diagnosing a subject as a candidate for the removal of a solid tumor without preoperative chemoradiation therapy. This method is particularly valuable for patients exhibiting genomic instability and elevated biomarkers in peripheral blood lymphocytes. The second patent addresses systems and methods for treating patients with a genetic predisposition to develop prostate cancer. This innovative approach evaluates peripheral blood cells for specific biomarkers and gene alterations that correlate with prostate cancer development.

Career Highlights

Sanjeevani Arora is affiliated with the Institute for Cancer Research, where he continues to push the boundaries of cancer treatment and diagnosis. His research is characterized by a commitment to improving patient outcomes through innovative methodologies.

Collaborations

Sanjeevani collaborates with notable colleagues, including Erica A. Golemis and Joshua Meyer, who contribute to his research endeavors and enhance the impact of his work in the field of cancer research.

Conclusion

Sanjeevani Arora's contributions to cancer research through his patents and innovative methods are making a significant impact in the medical field. His dedication to improving diagnosis and treatment for patients with solid tumors and prostate cancer showcases the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…